Abstract:In recent years, public health events have significantly impacted various aspects of human production and daily life, particularly in the domains of disease transmission and economic stability. While many scholars have primarily focused on the influence of public health events from the perspective of disease prevention and control, research examining their economic implications, especially regarding public health indices in the securities market, remains relatively scarce. Such studies are crucial for ensuring public health safety and stability. This paper employs the Bayesian Convolutional Neural Network (Bayes-CNN) model to predict financial market volatility influenced by public health events and conducts a comparative analysis. To validate the feasibility of this method, the model is used to analyze the impact of the COVID-19 pandemic on the CSI (China Securities Index) Medical Service Index. The results indicate significant differences in the volatility of the CSI Medical Service Index before and after the outbreak, particularly during the pandemic period. This study also enhances the validity and reliability of its conclusions by incorporating European data and employing the GARCH model. Relevant institutions and individual investors should adopt different regulatory and investment strategies based on the specifics of various public health events to prevent the outbreak of systemic financial risks that could affect social stability. This paper offers a new perspective and methodology for predicting financial market volatility under the influence of public health events, providing valuable insights for investors and decision-makers to better understand and respond to the potential impacts of such events on financial markets.

Risk Analysis for Baijiu Industry Based on CAPM Model during COVID-19

Baijiu Industry Analysis Based on Various Indicators: Kweichow Maotai, Luzhou Laojiao & Shanxi Fenjiu

The Impact of COVID-19 Pandemic on the Effectiveness of the CAPM Model: Evidence from the Chinese Market and Pharmaceutical Industry

Research on Chinese stock market based on CAPM: pre and post Covid-19 pandemic

Investor Sentiment and Stock Returns During the COVID-19 Pandemic

Risk Analysis of Continuously Rising and Falling Stock Yield Based on Copula-ACD Method

A Valuation Model for the Development of Sinovac Biological Company under COVID-19 Shock

Analysis of the Investment Value of The Listed Companies in The Liquor Industry Based on The Factor Analysis Method

A Study of the Impact of COVID-19 on the Chinese Stock Market Based on a New Textual Multiple ARMA Model

Corporate Financial Measures and Covid-19 Pandemic with Evidence from the Growth Enterprise Market of China’s Shenzhen Stock Exchange

An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic-Based on Cases of Dominant Listed Companies

Comparative analysis of volatility forecasting for healthcare stock indices amid public health crises: a study based on the Bayes-CNN model

Valuation Analysis of Medical Imaging Industry under COVID-19 in China

Representative Stock Analysis in Chinese Medical Industry and Relevant Investment Recommendations

Analysis of the Development and Prospects of the Baijiu Industry

Financial Performance Analysis of Listed Baijiu Companies

Empirical Analysis of New Energy Vehicle Industry Based on the CAPM Model

COVID-19 and financial market response in China: Micro evidence and possible mechanisms

Analysis of tail risk contagion among industry sectors in the Chinese stock market during the COVID-19 pandemic

The Relationship Between Enterprise Financial Risk and R&D Investment Under the Influence of the COVID-19

BILSTM Model for Machine Learning Stock Prediction and Portfolio Construction in the Context of Covid-19 Pandemic